Volume : 12, Issue : 01, January – 2025
Title:
NANOSUSPENSION: TO ENHANCE SOLUBILITY OF POORLY SOLUBLE BCS CLASS II DRUGS
Authors :
Sakshi R. Manekar, Gayatri V. Apotikar, Shubham U. Tikait , Swati P. Deshmukh
Abstract :
Nanosuspensions represent a promising formulation strategy to enhance the solubility and bioavailability of poorly soluble drugs, particularly those classified under Biopharmaceutical Classification System (BCS) Class II. This class encompasses drugs that exhibit high permeability but low solubility, posing significant challenges for effective therapeutic delivery. Nanosuspensions involve the reduction of drug particle size to the nanometer scale, leading to an increase in surface area and dissolution rate. This review explores the methodologies employed in the preparation of nanosuspensions, including wet milling, high-pressure homogenization, and precipitation techniques. Additionally, the physicochemical properties, stability considerations, and potential applications of nanosuspensions in drug delivery systems are discussed. The review highlights the advantages of this approach, such as improved solubility, enhanced drug stability, and the potential for targeted delivery. Furthermore, recent advancements and regulatory considerations in the development of nanosuspension formulations are examined, emphasizing their role in overcoming the solubility challenges faced by BCS Class II drugs.
Keywords : Nanosuspension ,Solubility enhancement, BCS Class II drugs, Drug delivery, High permeability, Poorly soluble drugs, Particle size reduction, Wet milling, High -pressure homogenization, Precipitation Techniques, Bioavailability, Physicochemical properties, Stability, Targeted delivery, Formulation development
Cite This Article:
Please cite this article in press Sakshi R. Manekar et al., Nanosuspension: To Enhance Solubility Of Poorly Soluble BCS Class II Drugs.,Indo Am. J. P. Sci, 2025; 12 (01).
Number of Downloads : 10
References:
1. Patel VR, Agrawal YK.Nanosuspension:An approach to enhance solubility of drugs. J Adv Pharm Tech Res. 2011; 2(2):81-87. Institute of Research and Development, Gujarat Forensic Sciences University, Gandhinagar, Gujarat, India.
2.Jakka V, Ramyamunagala G, Patnala DSP, Kuruba R. Nanosuspensions: a strategy to increase the solubility and bioavailability of poorly water-soluble drugs. J Adv Pharm Tech Res. 2023;16(5):33-40
3.Ma Y, Cong Z, Gao P, Wang Y. Nanosuspensions technology as a master key for nature products drug delivery and in vivo fate.European Journal of Pharmaceutical Sciences .2023; 185(2023):106425
4.Bhowmik D, Harish G, Duraivel S, Pragathi Kumar B, Raghuvanshi V, Sampath Kumar K. Nanosuspension – A novel approach in drug delivery system. The Pharma Innovation – Journal. 2013;1(12):50-63
5.Aldeeb MM, Wilar G, Suhandi C, Elamin KM, Wathoni N. Nanosuspension-based drug delivery systems for topical applications. International Journal of Nanomedicine. 2024; 9:825-844. Correspondence: Nasrul Wathoni, Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia.
6.Shahidulla SM, Miskan R, Sultana S. Nanosuspensions in pharmaceutical sciences: a comprehensive review. International Journal of Health Sciences and Research. 2023; 13(7):332-342.
7.Sinko PJ, editor. Martin’s physical pharmacy and pharmaceutical sciences:Wolters Klwer (India) Pvt Ltd,New Delhi; 2023:188-189
8.Jacob S, Nair AB, Shah J. Emerging role of nanosuspensions in drug delivery systems. Biomaterials Research. 2020; 24(3):1-16
9.Yadollahi R, Vasilev K, Simovic S. Nanosuspension technologies for delivery of poorly soluble drugs. J Nanomaterials. 2015;2015(1):216375.
10.Jadhav SP, Singh SK, Chawra HS. Review on nanosuspension as a novel method for solubility and bioavailability enhancement of poorly soluble drugs. Adv Pharmacology and Pharmacy. 2023;11(2):117-130.
11.Han J, Xiao B, Le PK, Mangwandi C. Enhancement of the solubility of BS class II drugs with MOF and MOF/GO composite materials: case studies of felodipine, ketoprofen, and ibuprofen. Materials.2023; 16:1-15.
12.Lakshmi P, Kumar GA. Nanosuspension technology: a review. International Journal of Pharmacy and Pharmaceutical Sciences. 2010; 2(4):35-40.
13.Attari Z, Kalvakuntla S, Reddy MS, Deshpande M, Rao CM, Koteshwara KB. Formulation and characterisation of nanosuspensions of BCS class II and IV drugs by combinative method. J Exp Nanoscience. 2016;11(4):276-288.
14.Jassim ZE, Rajab NA. Review on preparation, characterization, and pharmaceutical application of nanosuspension as an approach of solubility and dissolution enhancement. Journal of Pharmacy Research. 2018; 12(5):771-774.
15.Geetha G, Poojitha U, Khan KAA. Various techniques for preparation of nanosuspension – a review. International Journal of Pharma Research and Review.2014; 3(9):30-37.
16.Chinthaginjala H, Ahad HA, Reddy PG, Kodi K, Manchikanti SP, Pasam D. Nanosuspension as promising and potential drug delivery: a review. Int J Lifescience Pharma Res. 2020; 1:59-66.
17.Sinko PJ, editor. Martin’s physical pharmacy and pharmaceutical sciences:Wolters Klwer (India) Pvt Ltd,New Delhi; 2023:384-385
18. Gigliobianco MR, Casadidio C, Censi R, Di Martino P. Nanocrystals of poorly soluble drugs: drug bioavailability and physicochemical stability.Pharmaceutics. 2018; 10:134.
19.Banavath H, Raju KS, Ansari MT, Ali MS, Pattnaik G. Nanosuspension: an attempt to enhance bioavailability of poorly soluble drugs. Int J Pharm Sci Rev Res. 2010;1(9):1-11.
20.Chauhan NN, Patel NV, Suthar SJ, Patel JK, Patel MP. Micronization of BCS Class–II drugs by various approaches for solubility enhancement – a review. Research J. Pharm . and Tech. 2012; 5(8):999-1005.
21.Singh VK, Chandra D, Singh P, Kumar S, Pratap Singh A. Nanosuspension: way to enhance the bioavailability of poorly soluble drug. Int J Curr Trends Pharm Res. 2013;1(4):277-287.
22.Phatak A, Jorwekar P, Chaudhari PD. Nanosuspensions: a promising nanocarrier drug delivery system. Research Journal of Pharmaceutical Dosage Forms and Technology. 2011; 3(5):176-182.
23.Kheradkar VA, Mulla JAS. Nanosuspension: a novel technology for drug delivery. Asian J. Res. Pharm. Sci. 2023; 13(2):106-110.
24.Malgundkar HK, Pomaje MD, Nemade LS. Breaking barriers with nanosuspension: a comprehensive review. Biosci. Biotech. Res. Asia. 2024; 21(1):57-68.
25.Pawar P, Yadav A, Gharge V. Different techniques for preparation of nanosuspension with reference to its characterisation and various applications – a review.Asian J .Res. Pharm .Sci. 2018; 8(4):210-216.
26.Sutradhar KB, Khatun S, Luna IP. Increasing possibilities of nanosuspension. Journal of Nanotechnology. 2013; (1):12.
27.Shinde ME, Sonawane MP, Maru AD. Solubility enhancement of simvastatin by preparation of nanosuspension. Int. J. Pharm. Sci. Rev. Res. 2021;71(1):97-101.
28.Hajare A. Industrial Pharmacy-1. Abhyudaya Pragati, 1312, Shivaji Nagar , Pune :Nirali Prakashan; 2021:1.10-1.12
29.Hajare A. Pharmacy Pharmaceutics-1. Abhyudaya Pragati, 1312, Shivaji Nagar , Pune :Nirali Prakashan; 2021:1.1-1.3
30.Brahmankar DM, Jaiswal SB. Biopharmaceutics and pharmacokinetics. GT Karnal Road, Delhi: M K Jain for Vallabh Prakashan; 2019: 338-339
31.Sinko PJ, editor. Martin’s physical pharmacy and pharmaceutical sciences:Wolters Klwer (India) Pvt Ltd,New Delhi; 2023:392-393
32. Khar RK, SP Vyas, Ahmad FJ , Jain GK. Lachman/Liberman’s Industrial Pharmacy: CBS Publishers & Distributors Pvt Ltd ; 2013 : 907-946
33.Dhiman P, Bhatia M. Pharmaceutical applications of cyclodextrins and their derivatives. J Incl Phenom Macrocyclic Chem. 2020;98(3-4):171-86. Doi:10.1007/s10847-020-01029-3.